SynerFuse, in partnership with the Minneapolis-based University of Minnesota, South Bend (Ind.) Orthopaedics and RQM+, has completed the first proof-of-concept study of its electric transforaminal ...
For the one million people diagnosed with Parkinson's disease in the United States, Medtronic plc (NYSE:MDT), a global leader in healthcare technology, proudly announces U.S. Food and Drug ...
The FDA has approved BrainSense, an adaptive deep brain stimulation system that can adjust therapy for Parkinson’s disease in ...
The biggest technical challenge for adaptive deep brain stimulation (aDBS) is how small brain signals are, Medtronic's Scott ...
6don MSN
After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...
(NYSE: MDT) announced today that the FDA approved its BrainSense adaptive deep brain stimulation (aDBS) platform.
Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the ...
Starting today, people with Parkinson’s disease will have a new treatment option, thanks to U.S. Food and Drug Administration approval of groundbreaking new technology.
This patent relates to cochlear implant systems having a cochlear electrode, a stimulator in electrical communication with the cochlear electrode, an inner ear sensor, and a signal processor in ...
Kestra Medical recently filed a form S-1 to confirm its intent to go public through an initial public offering (IPO). In a filing fee schedule listed on the S-1, the Kirkland, Washington–based ...
The Tim and Caroline Reynolds Center for Spinal Stimulation at Kessler Foundation has become the first medical center in New Jersey to implant a spinal cord epidural stimulator in an individual with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback